RAMMF News and Press, RAMM Pharma From 04/20/21

TORONTO, April 20, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that the Uruguayan Minis...

RAMM Pharma (RAMMF) has commenced commercial sales of its NettaPet cannabidiol (“CBD”) enriched super premium quality dog food.NettaPet is the first product to be commercialized by RAMM’s wholly owned subsidiary NettaLife which focuses on the production, commercialization...

TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that it has commenced co...

Delta, Kelowna, BC - March 25, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insig...

RAMM Pharma (RAMMF) announces that it has initiated clinical trials studying the efficacy of its proprietary NettaVet pet cannabinoid formulation for the treatment of four pathologies in animals.The trials will be conducted in partnership with Universidad de la Republica de Uruguay ...

TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that it has initiated cl...